FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887953404> ?p ?o ?g. }

• W2887953404 abstract "Aim: The study aims to identify new therapeutic targets from cancer exosomes, which may spread drug resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in the treatment of non-small-cell lung cancer (NSCLC). Background: EGFR TKIs have exhibited extraordinary clinical efficacy in advanced lung cancer. However, their usefulness is compromised by drug resistance mediated by various mechanisms, including the emergence of a secondary EGFR T790M mutation. Exosomes are small membrane vesicles derived from the cellular phenomenon of membrane blebbing under both normal and pathological conditions. They mediate intercellular cross-talk by transferring receptors, antigens and cytokines from donor to recipient cells. It has been reported that EGFR TKI resistance mutation exists before drug exposure. Selective pressure from EGFR TKI therapy may thus cause the expansion of the latent resistant subclones, resulting in the emergence of a resistant phenotype in the entire tumor population. We hypothesize that exosomes may mediate the transfer of the secondary EGFR mutant or other mediators from the resistant subclones to neighboring sensitive cells. Method: The possible exosome-mediated transfer of secondary EGFR mutant (or other protein mediators) from EGFR T790M-bearing NSCLC (H1975) cells to a sensitive NSCLC cell line (HCC827) was evaluated. Exosomes were isolated from H1975 cells-conditioned medium by the standard differential centrifugation method. The secretion of protein mediators into exosomes by resistant H1975 cells was studied by protein array. The EGFR kinase activity of the exosomes was evaluated by biochemical assay. The uptake of fluorescence-labeled exosome from the resistant cells by the sensitive cells was visualized by fluorescence microscopy. The activation of the EGFR signaling pathway in the recipient sensitive cells after incubation with exosomes derived from the resistant cells was examined by Western blot analysis. Result: Exosomes were successfully isolated from H1975-conditioned medium and confirmed by the expression of exosomal markers CD63 and HSP70. Compared with exosomes derived from sensitive HCC827 cells, exosomes secreted from H1975 cells were enriched with apoptosis-regulating proteins including Src. H1975-derived exosomes increased the viability of HCC827 cells in the presence of gefitinib and inhibited the apoptosis induced by gefitinib. Western blot analysis showed that the exosomes can block the reduction of BCL-2 and full-length PARP, while abolishing the increase of BAX and cleaved PARP induced by gefitinib in HCC827 cells. Conclusion: H9175-derived exosomes may be involved in the spreading of drug resistance to EGFR TKIs by regulating cell apoptosis. New treatment strategies may be designed to target and inhibit this exosome-mediated transfer of mediators implicated in the acquired resistance to EGFR TKIs. Citation Format: Kenneth KW To, Christy WS Tong, Mia MX Wu. Cancer exosomes as a new mediator to spread drug resistance to EGFR tyrosine kinase inhibitors [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 1969." @default.
• W2887953404 created "2018-08-22" @default.
• W2887953404 creator A5024761721 @default.
• W2887953404 creator A5057792263 @default.
• W2887953404 creator A5085401301 @default.
• W2887953404 date "2018-07-01" @default.
• W2887953404 modified "2023-09-27" @default.
• W2887953404 title "Abstract 1969: Cancer exosomes as a new mediator to spread drug resistance to EGFR tyrosine kinase inhibitors" @default.
• W2887953404 doi "https://doi.org/10.1158/1538-7445.am2018-1969" @default.
• W2887953404 hasPublicationYear "2018" @default.
• W2887953404 type Work @default.
• W2887953404 sameAs 2887953404 @default.
• W2887953404 citedByCount "0" @default.
• W2887953404 crossrefType "proceedings-article" @default.
• W2887953404 hasAuthorship W2887953404A5024761721 @default.
• W2887953404 hasAuthorship W2887953404A5057792263 @default.
• W2887953404 hasAuthorship W2887953404A5085401301 @default.
• W2887953404 hasConcept C104317684 @default.
• W2887953404 hasConcept C121608353 @default.
• W2887953404 hasConcept C142724271 @default.
• W2887953404 hasConcept C145059251 @default.
• W2887953404 hasConcept C20518536 @default.
• W2887953404 hasConcept C2776256026 @default.
• W2887953404 hasConcept C2777930144 @default.
• W2887953404 hasConcept C2779438470 @default.
• W2887953404 hasConcept C2780580887 @default.
• W2887953404 hasConcept C2781261824 @default.
• W2887953404 hasConcept C2908647359 @default.
• W2887953404 hasConcept C42362537 @default.
• W2887953404 hasConcept C502942594 @default.
• W2887953404 hasConcept C54355233 @default.
• W2887953404 hasConcept C55493867 @default.
• W2887953404 hasConcept C62478195 @default.
• W2887953404 hasConcept C71924100 @default.
• W2887953404 hasConcept C86803240 @default.
• W2887953404 hasConcept C95444343 @default.
• W2887953404 hasConcept C99454951 @default.
• W2887953404 hasConceptScore W2887953404C104317684 @default.
• W2887953404 hasConceptScore W2887953404C121608353 @default.
• W2887953404 hasConceptScore W2887953404C142724271 @default.
• W2887953404 hasConceptScore W2887953404C145059251 @default.
• W2887953404 hasConceptScore W2887953404C20518536 @default.
• W2887953404 hasConceptScore W2887953404C2776256026 @default.
• W2887953404 hasConceptScore W2887953404C2777930144 @default.
• W2887953404 hasConceptScore W2887953404C2779438470 @default.
• W2887953404 hasConceptScore W2887953404C2780580887 @default.
• W2887953404 hasConceptScore W2887953404C2781261824 @default.
• W2887953404 hasConceptScore W2887953404C2908647359 @default.
• W2887953404 hasConceptScore W2887953404C42362537 @default.
• W2887953404 hasConceptScore W2887953404C502942594 @default.
• W2887953404 hasConceptScore W2887953404C54355233 @default.
• W2887953404 hasConceptScore W2887953404C55493867 @default.
• W2887953404 hasConceptScore W2887953404C62478195 @default.
• W2887953404 hasConceptScore W2887953404C71924100 @default.
• W2887953404 hasConceptScore W2887953404C86803240 @default.
• W2887953404 hasConceptScore W2887953404C95444343 @default.
• W2887953404 hasConceptScore W2887953404C99454951 @default.
• W2887953404 hasLocation W28879534041 @default.
• W2887953404 hasOpenAccess W2887953404 @default.
• W2887953404 hasPrimaryLocation W28879534041 @default.
• W2887953404 hasRelatedWork W1497552526 @default.
• W2887953404 hasRelatedWork W2063015373 @default.
• W2887953404 hasRelatedWork W2154556905 @default.
• W2887953404 hasRelatedWork W2573517532 @default.
• W2887953404 hasRelatedWork W2772972859 @default.
• W2887953404 hasRelatedWork W2784375925 @default.
• W2887953404 hasRelatedWork W2887953404 @default.
• W2887953404 hasRelatedWork W3030729391 @default.
• W2887953404 hasRelatedWork W3031530718 @default.
• W2887953404 hasRelatedWork W3032800087 @default.
• W2887953404 isParatext "false" @default.
• W2887953404 isRetracted "false" @default.
• W2887953404 magId "2887953404" @default.
• W2887953404 workType "article" @default.